+174%

est. 2Y upside i

HealthcareSeries B

Rank

#79

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Low

Birdie offers a substantial paper upside of ~174% probability-weighted over 2 years because the stale $186M valuation against $75.7M ARR implies only 2.5x revenue, while public healthcare SaaS comps trade at 4-7x.

Last updated: August 21, 2026

Bull (20%)+300%

Revenue reaches ~$120.6M by month 24; an AI/IPO-driven exit multiple of 7x forward revenue values Birdie at $844M. After 20pts dilution, common upside is +300% (capped).

Base (55%)+203%

Revenue grows to ~$120.6M; exit multiple normalizes to 5x within the public SaaS comp range, implying a $603M exit. After 20pts dilution, common upside is ~+203%.

Bear (25%)+9%

Multiple compresses to 2x on competitive/regulatory pressure, implying a $241M exit. This remains above the $62.4M preference, so common nets ~+9%; a sub-$62.4M exit would zero common.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

3350%

$62.4M of 1x preferred equals 33.5% of the $186.4M entry valuation; common only has meaningful value above $62.4M in an exit.

Dilution Risk

high

No financing since May 2022 and unprofitable operations make a new round likely, diluting common by ~20%.

Secondary Liquidity

none

No secondary market or tender offer observed; liquidity depends on a future round, M&A, or IPO.

Delivery — 3 roles

View all 6 open roles at Birdie →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Birdie's data — designed to show you've done your homework.

  • 1

    “What is the current 409A / option strike price, and how often is it refreshed?”

  • 2

    “What are net revenue retention and gross margin by customer size, and how does churn differ between enterprise and SMB?”

  • 3

    “What specific product or go-to-market changes will keep Birdie ahead of AlayaCare and HHAeXchange?”

Community

Valuation Sentiment

Our model estimates +174% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.